Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population ...

Future research into non-Hodgkin lymphoma treatments needs to explore long-term outcomes and a better understanding biologic ...

Patients with HIV can take both their antiretroviral therapy (ART) and treatment to prevent tuberculosis safely to prevent ...

A new single-use device reduces surgical site infections, improves recovery, and lowers costs after Cesarean (C-section) ...

Despite holding promise in a range of disease states, a variety of challenges prevent cell and gene therapies (CGTs) from ...

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

RWJBarnabas Health and Rutgers Cancer Institute unveil the Jack & Sheryl Morris Cancer Center—1 of only 13 freestanding ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

"The newer medications that are coming out, and a lot of them are approved, are much more focused on the problem," explains ...

A higher composite dietary antioxidant index was found to decrease the chances of American adults developing cataracts.

The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...